Court revives lawsuit against Pfizer's diversity fellowship Group claims Pfizer program discriminates against white, ...
UBS lowered the firm’s price target on Pfizer (PFE) to $29 from $31 and keeps a Neutral rating on the shares as part of a broader note on the ...
Leerink analyst David Risinger said he doesn’t ... he said. Risinger rates Pfizer shares Market Perform with a price target ...